Forefront Analytics, LLC Fusion Pharmaceuticals Inc. Transaction History

Forefront Analytics, LLC

  • $209 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$2.48 - $9.65 $42,085 - $163,760
-16,970 Reduced 50.38%
16,715 $160,000
Q3 2023

Nov 07, 2023
BUY
$2.37 - $4.63 $32,255 - $63,014
13,610 Added 67.8%
33,685 $87,000
Q2 2023

Aug 11, 2023
BUY
$3.47 - $5.33 $69,660 - $106,999
20,075 New
20,075 $93,000

Others Institutions Holding FUSN

# of Institutions
5
Shares Held
93K
Call Options Held
1.4K
Put Options Held
0
View Full List

About Fusion Pharmaceuticals Inc.

FUSN Quotes by TradingView
  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track This Portfolio

Track Forefront Analytics, LLC Portfolio

Follow Forefront Analytics, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forefront Analytics, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email